Ops-Watch Weekly Grant Opportunities Update March 26 April 1, 2016

Size: px

Start display at page:

Download "Ops-Watch Weekly Grant Opportunities Update March 26 April 1, 2016"

Darleen Welch
5 years ago
Views:

Ops-Watch Weekly Grant Opportunities Update March 26 April 1, 2016 Department of Commerce - National Institute of Standards and Technology - National Strategy for Trusted Identities in Cyberspace

1 Ops-Watch Weekly Grant Opportunities Update March 26 April 1, 2016 Department of Commerce - National Institute of Standards and Technology - National Strategy for Trusted Identities in Cyberspace (NSTIC) Federated Identity in Healthcare Pilot Program Proposal Due Date: June 1, NIST-NSTIC-02 Purpose: NIST is soliciting applications from eligible applicants to demonstrate the usage of federated online identity solutions for patients and providers across multiple healthcare providers (e.g., provider groups, regional healthcare systems, hospital systems). All applicants must meet all of the following requirements: Applicants must be hospitals or healthcare systems consisting of multiple hospitals, ambulatory sites, clinics or similar healthcare facilities. Applicants may be for-profit, not-for-profit or governmental (other than Federal government) entities located in the United States or its territories. Applicants must partner with at least one other healthcare organization in their locality/region. The partner organization should have anticipated overlap with the applicant organization of patients, physicians and other clinical staff (such as a physician practice group(s), clinic(s) and hospital(s)). The partner organization must be organizationally independent of the applicant and maintain a separate health information system from the applicant. Health information systems refer to any system that captures, stores, manages or transmits information related to the health of individuals or the activities of organizations that work within the health sector. NIST will not assist in matching organizations. Federal agencies (including facilities and components of the Veteran s Integrated Service Network of the Veteran s Health Administration) may participate in projects but may not receive NIST funding. Health - New Technologies for the Glycosciences (R43/R44)

2 Proposal Due Date: April 5, 2019 PA Purpose: This program aims to develop affordable tools and technologies for carbohydrate research. Areas of primary interest include new approaches for glycan synthesis, easily accessible analytical reagents and technologies for the study of glycoconjugates, and informatics tools for glycan data analysis. This SBIR program complements the Common Fund program Accelerating Translation of Glycoscience: Integration and Accessibility launched in 2015 to develop new methods, tools, and technologies for studying carbohydrates. Common Fund programs do not utilize the SBIR mechanisms. Health - New Technologies for the Glycosciences (R41/R42) Proposal Due Date: April 5, 2019 PA Purpose: This program aims to develop affordable tools and technologies for carbohydrate research. Areas of primary interest include new approaches for glycan synthesis, easily accessible analytical reagents and technologies for the study of glycoconjugates, and informatics tools for glycan data analysis. This SBIR program complements the Common Fund program Accelerating Translation of Glycoscience: Integration and Accessibility launched in 2015 to develop new methods, tools, and technologies for studying carbohydrates. Common Fund programs do not utilize the SBIR mechanisms. Health - NIH Small Research Grant Program (Parent R03) Proposal Due Date: May 7, 2019 $50,000 PA

3 Purpose: The NIH Small Research Grant Program supports small research projects that can be carried out in a short period of time with limited resources. This program supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. Health - NIH Director's Transformative Research Awards (R01) Proposal Due Date: October 7, 2016 RFA-RM Purpose: The NIH Director's Transformative Research Awards complement NIHs traditional, investigatorinitiated grant programs by supporting individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original and/or unconventional research with the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies. Little or no preliminary data are expected. Projects must clearly demonstrate the potential to produce a major impact in a broad area of biomedical or behavioral research. Department of Health and Human Services - Centers for Disease Control NCEZID - Capacity building for ecological surveillance of viral hemorrhagic fevers in Sierra Leone Proposal Due Date: June 1, $3,000,000 CDC-RFA-CK Purpose: Detection and monitoring the burden of infections for high consequence pathogens in animal reservoirs represent a critical step to mitigate and control outbreaks. These activities require a welldeveloped in-country capacity to perform collection of appropriate samples, detection and differential diagnostic using established laboratory methods for VHF, and curation of samples in a sustainable and secure manner. This FOA supports the establishment of such ecological surveillance program in forestdwelling animals to promote yearly monitoring of the burden of infections in these animals.

4 Eligibility Category: Others (see text field entitled "Additional Information on Eligibility" for clarification) Additional Eligibility Category: 2. Additional Information on Eligibility The 2014 West Africa Ebola virus outbreak that overwhelmed Sierra Leone, Guinea and Liberia s health systems is believed to have started from a single animal-to-human spillover event in the forest that links southeastern Guinea, eastern Sierra Leone and western Liberia. CDC is seeking a unique partner that is a public governmental institution of Sierra Leone (SL) that has: established programs in wildlife management including programs to train new scientists on wildlife management expert knowledge of forested areas in Sierra Leone scientific expertise in animal sample collection and processing expertise in molecular laboratory methods for EVD sustainable access to critical field sites in forested areas where the Ebola outbreak of is believed to have started, including existing linked to and/or buy-in from the communities surrounding these sites existing track-record managing a collaborative agreement experience with a U.S government agency miliarity operating in Sierra Leone as it relates to local laws and traditions, and government entities Department of Health and Human Services - Substance Abuse and Mental Health Services Admin - Targeted Capacity Expansion: Medication Assisted Treatment - Prescription Drug and Opioid Addiction (MAT-PDOA) grants Proposal Due Date: May 31, $11,000,000 $1,000,000 TI Purpose: The purpose of this program is to expand/enhance access to medication-assisted treatment (MAT) services for persons with opioid use disorder seeking or receiving MAT. This program targets states identified with having the highest rates of primary treatment admissions for heroin and opioids per capita, and prioritizes those states with the most dramatic increases for heroin and opioids, based on SAMHSA s Treatment Episode Data Set (TEDS): The desired outcomes include: 1) an increase in the number of admissions for MAT; 2) an increase in the number of clients receiving integrated care/treatment; 3) a decrease in illicit opioid drug use at 6-month follow-up; and 4) a decrease in the use of prescription opioids in a non-prescribed manner at 6-month follow-up. For the purpose of this FOA, integrated care/treatment is defined as the organized delivery and/or coordination of medical (including the use of Food and Drug Administration (FDA)-approved drugs [buprenorphine, methadone, naltrexone] for addiction), behavioral, social, peer, and other recovery support services provided to individual patients who have multiple healthcare needs in order to produce better overall health outcomes. MAT is defined as the use of FDA-approved opioid agonist medications (e.g., methadone, buprenorphine products, including buprenorphine/naloxone combination formulations and buprenorphine mono-product formulations) for the maintenance treatment of opioid use disorder and opioid antagonist medication (e.g., naltrexone products, including extended-release and oral formulations) in combination with behavioral therapies to prevent relapse to opioid use. MAT includes screening, assessment (which includes determination of severity of opioid use disorder, including presence of physical dependence and appropriateness for MAT), and case management. MAT is to be provided in combination with comprehensive substance use disorder treatment, including but not limited to: counseling, behavioral therapies, and, when needed, pharmacotherapy for cooccurring alcohol use disorder. MAT is to be provided in a clinically driven, person-centered, and individualized setting. This program addresses SAMHSA s Strategic Initiative on Health Care and Health

5 Systems Integration. For more information on SAMHSA s six strategic initiatives, you can visit The MAT-PDOA program seeks to address behavioral health disparities among racial, ethnic, sexual, and gender identity minority populations by encouraging the implementation of strategies to decrease the differences in access, service use, and outcomes among the racial and ethnic minority populations served. (See PART II: Appendix G Addressing Behavioral Health Disparities.) The MAT-PDOA program is one of SAMHSA s services grant programs. SAMHSA intends that its services grants result in the delivery of services as soon as possible after award. Service delivery should begin by the 4th month of the project at the latest. Eligibility is limited to 28 states identified with having the highest rates of primary treatment admissions for heroin and opioids per capita, and prioritizes those states with the most dramatic increases for heroin and opioids, based on SAMHSA s Treatment Episode Data Set (TEDS): , (see Appendix V for a list of eligible states). The application must be submitted by the Single State Agency (SSA) for Substance Abuse within the state. Eligibility has been limited to these states because an analysis of TEDS data demonstrates that they represent the highest rates of primary treatment admissions with heroin and opiates per capita. In addition, SAMHSA has identified 11 of these states (see Appendix VI) that have demonstrated a dramatic increase of 40 percent or more in admissions for the treatment of opiates and heroin in recent years and will be given priority for funding. This approach is consistent with the language used to describe the program in the FY 2016 Omnibus language. FY 2015 MAT-PDOA grantees funded under announcement TI are not eligible to apply for this program. Department of Health and Human Services - Substance Abuse and Mental Health Services Admin - Strategic Prevention Framework for Prescription Drugs (SPF Rx) Proposal Due Date: May 31, $9,290,395 $371,616 SP Purpose: The SPF Rx grant program provides an opportunity for states, U.S. territories, pacific jurisdictions (herein referred to as states ), and tribal entities that have completed a Strategic Prevention Framework State Incentive Grant (SPF SIG) to target the priority issue of prescription drug misuse. The program is designed to raise awareness about the dangers of sharing medications and work with pharmaceutical and medical communities on the risks of overprescribing to young adults. SPF Rx will also raise community awareness and bring prescription drug abuse prevention activities and education to schools, communities, parents, prescribers, and their patients. In addition, SAMHSA will track reductions in opioid overdoses and the incorporation of Prescription Drug Monitoring Program (PDMP) data into needs assessments and strategic plans as indicators of the program s success. PDMPs are state-run databases used to track the prescribing and dispensing of controlled prescription drugs to patients. They are designed to monitor this information for suspected abuse or diversion (i.e., channeling drugs into illegal use), and can give a prescriber or pharmacist critical information regarding a patient s controlled substance prescription history. State applicants must have a fully operational PDMP in order to apply for the SPF Rx program. Tribes must coordinate with the state run PDMPs to identify opportunities for collaboration that will limit overprescribing in tribal communities.

6 Eligibility is limited to these entities because they have the greatest likelihood of achieving success through the SPF Rx grant program. Having completed the SPF process, these entities have the necessary experience and background for implementation: 1) an established state/tribal infrastructure and system in place rooted in both the SABG and the SPF prevention model that allows them to quickly build capacity in communities of need, mobilize those communities, and ensure accurate data collection and reporting at the community level; 2) integration of the SPF-based process into their overall state and tribal prevention systems, ensuring a strong, data-driven focus on identifying, selecting, and implementing effective, evidence-based prevention programs, policies, and practices; 3) experience in working collaboratively with communities to achieve substance misuse prevention goals; 4) familiarity and experience with the alignment of behavioral health with primary prevention; 5) a history of building comprehensive state and tribal level prevention systems over time; and 6) the required state run prescription drug monitoring program. Department of Health and Human Services - Substance Abuse and Mental Health Services Admin - Grants to Prevent Prescription Drug/Opioid Overdose-Related Deaths (PDO) Proposal Due Date: May 31, $11,000,000 $11,000,000 SP Purpose: The purpose of this program is to reduce the number of prescription drug/opioid overdose-related deaths and adverse events among individuals 18 years of age and older by training first responders and other key community sectors on the prevention of prescription drug/opioid overdose-related deaths and implementing secondary prevention strategies, including the purchase and distribution of naloxone to first responders. FY 2016 Appropriations language directed SAMHSA to award these funds to states to prevent opioidrelated deaths. This language also noted that SAMHSA should support the use of SABG funds for opioid safety education and training. Therefore, eligibility for this program is limited to states that receive SABG funds. Health - Partnerships for Countermeasures against Select Pathogens (R01) Proposal Due Date: October 3, 2016 $10,000,000

7 RFA-AI Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications for milestone-driven projects focused on preclinical development of lead candidate countermeasures (therapeutics, vaccines and related technologies, or diagnostics) against select NIAID Emerging Infectious Diseases/Pathogens. Applications must include a Product Development Strategy attachment and demonstrate substantive investment by at least one industrial participant. Health - NIH Research Project Grant (Parent R01) Proposal Due Date: May 7, 2019 PA Purpose: The NIH Research Project Grant supports a discrete, specified, circumscribed project in areas representing the specific interests and competencies of the investigator(s). The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions. Health - NIH Pioneer Award Program (DP1) Proposal Due Date: September 2, 2016 $700,000 RFA-RM Purpose: The NIH Directors Pioneer Award initiative complements NIH's traditional, investigator-initiated grant programs by supporting individual scientists of exceptional creativity who propose pioneering and possibly transforming approaches to addressing major biomedical or behavioral challenges that have the potential to produce an unusually high impact on enhancing health, lengthening life, and reducing illness

8 and disability. To be considered pioneering, the proposed research must reflect substantially different scientific directions from those already being pursued in the investigators research program or elsewhere. Department of Health and Human Services - Food and Drug Administration - Refine, Complete, and Publish Data Standards for Animal Efficacy Studies and Natural History Studies for Animal Rule Applications (U01) Proposal Due Date: June 3, $250,000 $250,000 RFA-FD Purpose: Electronic data standards are needed for the animal efficacy studies and natural history studies for Animal Rule applications (see 21 CFR for drugs and 21 CFR for biological products). CDER is seeking organization(s) to refine and complete its preliminary work in this area and to publish a complete set of voluntary consensus standards for these studies, incorporating the relevant current electronic data standards from Standard for Exchange of Nonclinical Data (SEND) and Study Data Tabulation Model (SDTM) and creating any new standards needed to characterize data from these studies. Health - NIH Director's New Innovator Award Program (DP2) Proposal Due Date: September 9, $80,000,000 $1,500,000 RFA-RM Purpose: The NIH Directors New Innovator (DP2) Award initiative supports a small number of early stage investigators of exceptional creativity who propose bold and highly innovative new research approaches that have the potential to produce a major impact on broad, important problems in biomedical and behavioral research. The New Innovator Award initiative complements ongoing efforts by NIH and its Institutes and Centers to fund early stage investigators through R01 grants, which continue to be the major sources of NIH support for early stage investigators. The NIH Directors New Innovator Award initiative is a component of the High Risk - High Reward Research Program of the NIH Common Fund.

9 Department of Justice - National Institute of Justice - Research and Evaluation on Identity Theft and Services to Victims of Identity Theft Proposal Due Date: June 1, $1,500,000 $1,500,000 NIJ Purpose: This solicitation seeks to build knowledge and evidence related to strategies, practices, and programs that serve victims of identity theft. The overall purpose of these services is to help victims minimize the damage, restore the security of their accounts and personal information, and recover from the experience. This funding will support research and evaluation projects that build knowledge about the consequences of identity theft and improve the quality of services to victims of identity theft. National Science Foundation - EPSCoR Research Infrastructure Improvement Program Track-1: Letter of Intent Deadline Date: July 5, 2016 Proposal Due Date: August 2, 2016 $28,000, Purpose: The Experimental Program to Stimulate Competitive Research (EPSCoR) is designed to fulfill the mandate of the National Science Foundation (NSF) to promote scientific progress nationwide. A jurisdiction is eligible to participate in EPSCoR programs if its level of NSF research support is equal to or less than 0.75 percent of the total NSF research and related activities budget for the most recent three year period (see eligibility table). Through this program, NSF establishes partnerships with government, higher education, and industry that are designed to effect sustainable improvements in a jurisdiction's research infrastructure, Research and Development (R&D) capacity, and hence, its R&D competitiveness. Research Infrastructure Improvement Track-1 (RII Track-1) awards provide up to $20 million total for 5 years to support physical, human, and cyber infrastructure improvements in research areas selected by the jurisdiction's EPSCoR steering committee as having the best potential to improve future R&D competitiveness of the jurisdiction.

10 National Science Foundation - Tectonics Proposal Due Date: July 8, $9,250,000 $500,000 $30, Purpose: The Tectonics Program supports a broad range of field, laboratory, computational, and theoretical investigations aimed at understanding the deformation of the terrestrial continental lithosphere (i.e. above the lithosphere-asthenosphere boundary). The Program focuses on deformation processes and their tectonic drivers that operate at any depth within the continental lithosphere, on time-scales of decades/centuries (e.g. active tectonics) and longer, and at micro- to plate boundary/orogenic belt lengthscales.

BJA Harold Rogers PDMP National Meeting on Data Driven Multi-Disciplinary Approaches to Reducing Rx Abuse

BJA Harold Rogers PDMP National Meeting on Data Driven Multi-Disciplinary Approaches to Reducing Rx Abuse SAMHSA Programs to Address Prescription Drug Misuse and Abuse Jinhee Lee, PharmD Division of Pharmacologic Therapies Center for Substance Abuse Treatment Substance Abuse and Mental Health Services Administration